TMC Life Sciences Bhd 2020 AR2
The report outlines TMC Life Sciences Berhad's performance and sustainability initiatives for the ten-month financial period ended June 30, 2020. Despite challenges from the COVID-19 pandemic, the group generated a direct economic value of RM207 million and maintained a strong cash balance of RM136.5 million. Key highlights include the implementation of the QUASR incident reporting system to enhance patient safety and obtaining MSQH accreditation for Thomson Hospital Kota Damansara. Additionally, the company reduced its clinical waste by 13% to 84.3 tonnes and decreased electricity consumption by 23% to 5,378,386 kWh.
Company: TMC Life Sciences Bhd
Sector: Healthcare & social services
Country: Malaysia
Year: 2020
Type: AR2
Pages: 176
Back to company
TMC Life Sciences Bhd
Annual Report
The report outlines TMC Life Sciences Berhad's performance and sustainability initiatives for the ten-month financial period ended June 30, 2020. Despite challenges from the COVID-19 pandemic, the group generated a direct economic value of RM207 million and maintained a strong cash balance of RM136.5 million. Key highlights include the implementation of the QUASR incident reporting system to enhance patient safety and obtaining MSQH accreditation for Thomson Hospital Kota Damansara. Additionally, the company reduced its clinical waste by 13% to 84.3 tonnes and decreased electricity consumption by 23% to 5,378,386 kWh.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Sep 1, 2019 - Jun 30, 2020
Fiscal Year
2020
Published
Nov 4, 2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Total Waste
Women on Board
Employees